Identifying surrogate markers in real-world comparative effectiveness research
From MaRDI portal
Publication:6629372
DOI10.1002/SIM.9569zbMATH Open1547.62255MaRDI QIDQ6629372FDOQ6629372
Xuan Wang, Tianxi Cai, Author name not available (Why is that?)
Publication date: 29 October 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
double robustnesssemi-nonparametric estimationsurrogate markercomparative effectiveness researchproportion of treatment effect explainedinflammatory bowel disease
Cites Work
- Title not available (Why is that?)
- Title not available (Why is that?)
- Title not available (Why is that?)
- A simple resampling method by perturbing the minimand
- On the Cox Model With Time-Varying Regression Coefficients
- Causal Inference for Statistics, Social, and Biomedical Sciences
- Estimation of Regression Coefficients When Some Regressors Are Not Always Observed
- Surrogate measures and consistent surrogates
- A Measure of the Proportion of Treatment Effect Explained by a Surrogate Marker
- Irregular Identification, Support Conditions, and Inverse Weight Estimation
- Causal Inference Using Potential Outcomes
- Non-parametric analysis of a generalized regression model. The maximum rank correlation estimator
- The Limiting Distribution of the Maximum Rank Correlation Estimator
- Overlap in observational studies with high-dimensional covariates
- Inference on finite-population treatment effects under limited overlap
- Model-free approach to quantifying the proportion of treatment effect explained by a surrogate marker
- Robust Approach to Combining Multiple Markers to Improve Surrogacy
Cited In (1)
This page was built for publication: Identifying surrogate markers in real-world comparative effectiveness research
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6629372)
